Keyphrases
High Risk
100%
Infection Risk
100%
Neutropenia
100%
Cancer Risk
100%
Aging
100%
Fluoroquinolones
100%
Elderly People
100%
Hematological Malignancies
50%
Central Nervous System
50%
Disease-related
50%
Older Patients
50%
Chemotherapy
50%
Elderly Patients
50%
Type 1 Diabetes Mellitus (T1DM)
50%
Chronic Kidney Disease
50%
Patients with Cancer
50%
Cardiac Disease
50%
Cancer Patients
50%
Treatment Dose
50%
Solid Tumors
50%
Antibiotic Use
50%
Immune System
50%
Pseudomonas Aeruginosa (P. aeruginosa)
50%
Treatment Efficacy
50%
Aspergillus Fumigatus
50%
Emphysema
50%
Medical Conditions
50%
Tolerability
50%
Opportunistic Infections
50%
Older People
50%
Tumor Formation
50%
Immunosuppressive Regimens
50%
Disease Treatment
50%
Cytomegalovirus Infection
50%
Electrolyte Disturbances
50%
Myelosuppression
50%
Infectious Complications
50%
Empirical Therapy
50%
Treatment-related
50%
Fluoroquinolone Prophylaxis
50%
Vascular Catheter
50%
Dose Intensity
50%
Antibiotic Prophylaxis
50%
Quinolones
50%
Antineoplastic Drugs
50%
Antimicrobial Spectrum
50%
Resistant Bacteria
50%
Immunosenescence
50%
Neutropenic Infection
50%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Quinolone Derivative
80%
Infection
60%
Neutropenia
40%
Combination Therapy
20%
Hematologic Malignancy
20%
Chemotherapy
20%
Carcinogenesis
20%
Immunosuppressive Agent
20%
Solid Malignant Neoplasm
20%
Chronic Kidney Failure
20%
Heart Disease
20%
Infectious Agent
20%
Pseudomonas aeruginosa
20%
Infectious Complication
20%
Diabetes Mellitus
20%
Antiinfective Agent
20%
Aspergillosis
20%
Tolerability
20%
Opportunistic Infection
20%
Electrolyte Disturbance
20%
Bone Marrow Suppression
20%
Emphysema
20%
Cytomegalovirus Infection
20%
Antibiotic Prophylaxis
20%
Diseases
20%